Health
Mint explainer: why is India opening new entry gateways for medicines and medical devices?
By Katherine Langford
The iPhone effect in healthcare: How Mounjaro is rewriting the economics of India’s pharma market
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →Editor-in-Chief · Wednesday, November 4, 2026 at 11:27 AM · 1 min read
Like eager buyers queuing for the latest iPhone, urban Indians are chasing next-generation weight-loss injections regardless of price. Eli Lilly’s Mounjaro has dethroned long-time bestseller Augmentin, sparking an unprecedented market boom for GLP-1 drugs.
Up nextMint explainer: why is India opening new entry gateways for medicines and medical devices?Health · 1 min read
